BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 30567565)

  • 1. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.
    Pothuraju R; Rachagani S; Junker WM; Chaudhary S; Saraswathi V; Kaur S; Batra SK
    J Exp Clin Cancer Res; 2018 Dec; 37(1):319. PubMed ID: 30567565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.
    Quoc Lam B; Shrivastava SK; Shrivastava A; Shankar S; Srivastava RK
    J Cell Mol Med; 2020 Jul; 24(14):7706-7716. PubMed ID: 32458441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses.
    Molina-Montes E; Coscia C; Gómez-Rubio P; Fernández A; Boenink R; Rava M; Márquez M; Molero X; Löhr M; Sharp L; Michalski CW; Farré A; Perea J; O'Rorke M; Greenhalf W; Iglesias M; Tardón A; Gress TM; Barberá VM; Crnogorac-Jurcevic T; Muñoz-Bellvís L; Dominguez-Muñoz JE; Renz H; Balcells J; Costello E; Ilzarbe L; Kleeff J; Kong B; Mora J; O'Driscoll D; Poves I; Scarpa A; Yu J; Hidalgo M; Lawlor RT; Ye W; Carrato A; Real FX; Malats N;
    Gut; 2021 Feb; 70(2):319-329. PubMed ID: 32409590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complexities of obesity and diabetes with the development and progression of pancreatic cancer.
    Bao B; Wang Z; Li Y; Kong D; Ali S; Banerjee S; Ahmad A; Sarkar FH
    Biochim Biophys Acta; 2011 Apr; 1815(2):135-46. PubMed ID: 21129444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and cancer pathogenesis.
    Berger NA
    Ann N Y Acad Sci; 2014 Apr; 1311():57-76. PubMed ID: 24725147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Type 2 Diabetes in Pancreatic Cancer.
    George S; Jean-Baptiste W; Yusuf Ali A; Inyang B; Koshy FS; George K; Poudel P; Chalasani R; Goonathilake MR; Waqar S; Mohammed L
    Cureus; 2022 Jun; 14(6):e26288. PubMed ID: 35898377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and pancreatic cancer.
    Li D
    Mol Carcinog; 2012 Jan; 51(1):64-74. PubMed ID: 22162232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
    Biadgo B; Abebe M
    Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents.
    Takahashi M; Mutoh M; Ishigamori R; Fujii G; Imai T
    Semin Immunopathol; 2013 Mar; 35(2):203-27. PubMed ID: 22955327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.
    Li D; Abbruzzese JL
    Clin Cancer Res; 2010 Sep; 16(17):4313-8. PubMed ID: 20647474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and pancreatic cancer.
    Cui Y; Andersen DK
    Endocr Relat Cancer; 2012 Oct; 19(5):F9-F26. PubMed ID: 22843556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Gut Microbiota in the development of obesity and Diabetes.
    Baothman OA; Zamzami MA; Taher I; Abubaker J; Abu-Farha M
    Lipids Health Dis; 2016 Jun; 15():108. PubMed ID: 27317359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and pancreatic cancer: An update of epidemiological evidence and molecular mechanisms.
    Zhou B; Wu D; Liu H; Du LT; Wang YS; Xu JW; Qiu FB; Hu SY; Zhan HX
    Pancreatology; 2019 Oct; 19(7):941-950. PubMed ID: 31447281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [THE FACTORS OF THE PROGRESSION OF METABOLIC DISORDERS IN THE PANCREAS IN PATIENTS WITH ASSOCIATED CLINICAL VARIANTS OF THE CHRONIC PANCREATITIS AND TYPE 2 DIABETES MELLITUS].
    Zhuravlyova LV; Shekhovtsova YO
    Lik Sprava; 2015; (5-6):46-51. PubMed ID: 27089715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans.
    Takahashi M; Hori M; Ishigamori R; Mutoh M; Imai T; Nakagama H
    Cancer Sci; 2018 Oct; 109(10):3013-3023. PubMed ID: 30099827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pancreatitis, pancreatic cancer and obesity: hypothesis and facts].
    Grigor'eva IN; Efimova OV; Suvorova TS; Tov NL
    Eksp Klin Gastroenterol; 2014; (9):4-10. PubMed ID: 25916125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the association between obesity and inflammation may lead to insulin resistance and cancer.
    Amin MN; Hussain MS; Sarwar MS; Rahman Moghal MM; Das A; Hossain MZ; Chowdhury JA; Millat MS; Islam MS
    Diabetes Metab Syndr; 2019; 13(2):1213-1224. PubMed ID: 31336467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, pancreatitis, and pancreatic cancer.
    Gumbs AA
    Obes Surg; 2008 Sep; 18(9):1183-7. PubMed ID: 18563497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.
    Eibl G; Cruz-Monserrate Z; Korc M; Petrov MS; Goodarzi MO; Fisher WE; Habtezion A; Lugea A; Pandol SJ; Hart PA; Andersen DK;
    J Acad Nutr Diet; 2018 Apr; 118(4):555-567. PubMed ID: 28919082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms behind the link between obesity and gastrointestinal cancers.
    Tilg H; Moschen AR
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):599-610. PubMed ID: 25194178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.